Icon

CYLERT (nda016832)- (18.75MG,37.5MG,75MG)

PEMOLINE ABBOTT
18.75MG,37.5MG,75MG
No No
Expired Expired
None None
None No
CYLERT (pemoline) is indicated in Attention Deficit Hyperactivity Disorder (ADHD). Because of its association with life threatening hepatic failure, CYLERT should not ordinarily be considered as first line therapy for ADHD.
0 0 0
Total Other Developers None
Drugs with Suitability No
18.75MG ** ** - - -
37.5MG ** ** - - -
75MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.